Related Experiment Video
Updated: Feb 23, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
Recalling feature bindings differentiates Alzheimer's disease from frontotemporal dementia
Mario Amore Cecchini1, Mônica Sanches Yassuda2,3, Valéria Santoro Bahia1
1Department of Neurology, School of Medicine, University of São Paulo, Av. Arlindo Bettio, São Paulo, SP, 1000, Brazil.
The short-term memory binding (STMB) test reveals specific deficits in Alzheimer's disease (AD) patients compared to controls and behavioral variant frontotemporal dementia (bvFTD) patients. This cognitive marker aids in differentiating AD, offering a new diagnostic tool.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Clinical Neurology
Background:
- Distinguishing Alzheimer's disease (AD) from behavioral variant frontotemporal dementia (bvFTD) is clinically challenging.
- Existing cognitive markers often lack specificity for early differential diagnosis.
- Short-term memory binding (STMB) involves integrating and temporarily holding information, a process potentially affected in neurodegenerative diseases.
Purpose of the Study:
- To determine if free recall deficits in the STMB test can differentiate patients with mild AD from those with mild bvFTD and cognitively intact adults.
- To evaluate the diagnostic accuracy of the STMB test in distinguishing between these groups.
Main Methods:
- A cohort of 32 healthy adults, 35 mild AD patients, and 18 mild bvFTD patients completed the STMB test.
- Free recall performance was analyzed to assess memory binding abilities.
- Receiver-operating characteristic (ROC) analyses were performed to evaluate diagnostic accuracy.
Main Results:
- AD patients exhibited significantly poorer performance on the STMB test compared to both controls and bvFTD patients.
- bvFTD patients and controls showed comparable performance on the STMB test.
- The bound condition of the STMB test demonstrated high accuracy in discriminating AD from controls (AUC=0.853) and AD from bvFTD (AUC=0.794).
Conclusions:
- Deficits in short-term memory binding appear specific to Alzheimer's disease.
- The free recall STMB test shows potential as a clinical tool for the differential diagnosis of AD.
- The STMB test may serve as a valuable cognitive marker for identifying Alzheimer's disease.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Treatment
Role of Cerebellum and Prefrontal Cortex in Memory
Neural Regulation

